Legacy Research Phase Concluded
Development and fulfillment for AOD9604 5mg has been prioritized for next-generation research compounds. We recommend exploring our state-of-the-art triple-agonist formulation.
AOD9604 5mg
Intensive concentration for accelerated lipolysis research and advanced protocols. Modified growth hormone fragment for lipolysis and lipid metabolism studies.
Secure checkout and fulfillment via Particle Peptides (Official 2026 Partner).
SKU: BBL-17-5mg-seo
Fulfillment: Direct from Particle Peptides EU
Product Overview
Intensive concentration for accelerated lipolysis research and advanced protocols. Modified growth hormone fragment for lipolysis and lipid metabolism studies.
This research-grade peptide is distributed in partnership with Particle Peptides to ensure maximum freshness and rapid delivery. Each batch undergoes rigorous third-party testing including HPLC and mass spectrometry.
Related Research Peptides
Tirzepatide
Tirzepatide research compound. Dual GLP-1/GIP receptor agonist used in metabolic pathway research and incretin hormone studies. For qualified researchers conducting scientific experiments only.
AOD9604
AOD9604 research peptide. Modified growth hormone fragment for lipolysis and lipid metabolism studies. Used in fat metabolism research without affecting glucose homeostasis. For laboratory research purposes only.
Tirzepatide 5mg
starting concentration for initial titration and concentration-finding protocols. Dual GLP-1/GIP receptor agonist used in metabolic pathway research.
Tirzepatide 10mg
Standard maintenance concentration for established metabolic research protocols. Dual GLP-1/GIP receptor agonist.
€79
Partner Stock